Physician profile
David E Demik
NPI 1487181160
$14,424.26
in general payments reported to CMS, 2019-2025
7 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.78 · 2022: $3,805 · 2023: $4,168 · 2024: $6,144 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,671 · Travel and Lodging: $3,204 · Education: $2,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,671.14 |
| Travel and Lodging | $3,204.35 |
| Education | $2,730.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $6,212.53 | 2022-2025 | Persona, Rosa, Arcos |
| Smith+Nephew, INC. | $5,637.05 | 2022-2023 | Real Intelligence, Journey II, Redapt |
| Stryker Corporation | $1,421.45 | 2022-2024 | Mako, Accolade, Triathlon |
| Depuy Synthes Sales INC. | $886.31 | 2019-2025 | Actis, Inhance, Tfn-Advance |
| Davol INC. | $121.20 | 2022 | |
| Medacta USA, INC. | $86.50 | 2023 | Gmk Sphere |
| Medical Device Business Services, INC. | $59.22 | 2024 | Attune |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Demik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.